Prevention committee

Prevention committee

ESGO Prevention 2

The Prevention Committee was established in 2019 to fulfil the ESGO vision: Best treatment and prevention in gynaecological cancer. ESGO has set as its mission to improve the health and well-being of women with gynaecological cancers through prevention, research, excellence in care and education. The Prevention Committee is therefore one of the cornerstones to ensure the fulfilment of its mission.

The Chair of the Prevention Committee is Prof. Murat Gultekin.

Committee Goals

  • Facilitate systematic research, issue scientific publications, and disseminate findings in the prevention and treatment of pre-invasive diseases.
  • Raise public and governmental awareness and advocate about gynaecological cancers, their prevention and treatment through ENGAGe.
  • Collaborate with professional societies, patient advocacy organisations, policymakers and other stakeholders to advance gynaecological cancers prevention and care.
  • Contribute to cervical cancer elimination in Europe in line with the WHO elimination programme 2030. Decrease mortality and extend life of gynaecological cancer patients in line with the EU Beat the cancer plan.

Committee Structure

 Prevention Committee Chair: Murat Gultekin












Marc Arbyn, Laia Bruni, Livia Giordano, Mihaela Grigore, Elmar Joura, Vesna Kesic, Maria Kyrgiou, Patrick Petignat, Mario Preti, Jalid Sehouli, Icó Tóth, Andreas Ullrich, Alexandra Wagner, Ignacio Zapardiel





ENYGO fellows: Nicolo Bizzarri, Taja Bracic, Joana Kacperczyk-Bartnik, Natalia Rodriguez, Nadja Taumberger, Charalampos Theofanakis

Cooperation with key stakeholders


World Health Organization has launched ''Cervical Cancer Elimination Program'' on November 19, 2020.

The program asks the countries to vaccinate the girls under 15 years of age (90% coverage), to screen females by minimal two times when they are 35 and 45 (70%) coverage and to treat the lesions detected appropriately (in 90% of cases).

Modelling studies show that if all countries can implement the program until 2030 and can achieve these targets, there will be a 30% reduction in cervical cancer mortality by 2030 and the cervical cancer may be eliminated until the end of this century (namely incidence less than 4 \ 100.000).


ESGO Prevention committee has joined in to fulfil the WHO cervical cancer elimination strategy as a leading European actor in prevention.

Committee webinars

Upcoming webinars 2023:

You may look forward to our next HPV related topics in March. Stay tuned for more information.

Committee Publications

Publications 2022

Expected in 2022:

  • ESGO-ISSVD-EFC-ECSVD Consensus statement on the management of pre-invasive
    vaginal lesions, V. Kesic, expected to publish as joint publication in IJGC and LJGTD
  • Self-tests in pregnant women (in process of publication)
  • VALCOLP, M. Arbyn

Expected in 2023:

  • Vaginal flora in gynaecological cancers, M. Kyrgiou
  • Management of pre-invasive cervical lesions CIN 1,2,3, M. Kyrgiou
  • Treatment of CIN2, M. Kyrgiou
  • Accuracy of methods that predict failure of cervical pre-cancer treatment, M. Arbyn
  • Value of endocervical curettage at the time of cone biopsy, A. Wagner
  • Quality assurance for HPV testing in the context of screening in the framewaork of HPV LabNet, A. Picconi
  • Colposcopy gallery, M. Grigore
Publications 2021
Publications 2020
Publications 2019

European projects

RISCC: Risk-based Screening for Cervical Cancer

ESGO/ENGAGe is involved in the Horizon 2020 RISCC project.

Within the RISCC project ESGO / ENGAGe is responsible for the co-creation of the e-health/m-health platform for risk based cervical cancer screening and for the dissemination of the results to 12 ENGAGe member countries. This project is planned for five years and intended to terminate in 2025.

For more information about the ESGO/ENGAGe involvement please use the following link.

Events of our partners

Upcoming events:

2nd EFC Interactive Learning Webinar for Colposcopists

May 18, 2022

This webinar is organised in collaboration with the French Colposcopy Society and will take place on 18th May 2022 at 6.00 pm CET.

Register before 16th May on our website (link to website).

Here is the link to the webinar website, where participants can register:


MSD for Mothers - MSD за майките

May 19, 2022

This webinar is organised by MSD Bulgaria and we are delighted to have our Prevention Committee members Dr. Andreas Ullrich as a speaker.

Andreas will present the topic EU policies for maternal mortality prevention and risk group support - please register and listen to his speech at 4:45 – 4:55 pm EEST. 

Register on the following link.

EFC Congress Helsinki

June 9-11, 2022

European Federation for Colposcopy organises yearly Congress which will take place in a hybrid format - physically in Helsinki and online. You can find more information about the Congress on the EFC website.

ESGO Prevention Committee speakers are invited to participate at this event too. You may look forward to:

Maria Kyrgiou (UK):

  • Keynote Lecture 1c: HPV vaccination after treatment of CIN
  • Cervical disease and vaginal microbiome: the systems biology

Marc Arbyn (Belgium): Self sampling

Vesna Kesic (Serbia): Prevention of cervical cancer in Serbia – opportunities and limitations


Register on the following link.


The agenda of the webinar is available here.




Prevention Committee awards

Dr. Murat Gultekin was awarded the IGCS Distinguished Advocacy Award for his extensive and tireless efforts to unify advocacy NGOs throughout Europe, forming ENGAGe. As the leading founder of HPV DNA Screening, Mobile Trucks and Central Mammography Report Unit, cancer registry systems and community- based palliative care system he is partly responsible for major innovations in cancer screening in Turkey and around the world. For more info visit the IGCS website.